Tuesday, February 11, 2025
Happening Now

Johnson & Johnson pauses COVID vaccine trial over sick participant

The New Jersey-based pharmaceuticals giant is the latest to halt a major coronavirus vaccine trial over a single unexplained illness. Source

Share